RILASTIL HYDROTENSEUR MATT RESTRUCTURING GEL CREAM 40ML
Rilastil Hydrotenseur Matt is an advanced anti-wrinkle treatment specifically formulated for combination and oily skin types. This lightweight gel-cream works to restructure the skin’s architecture, improving elasticity and reducing the depth of wrinkles while providing a sophisticated mattifying effect to control excess shine.
43.95 د.ا
Only 7 left in stock
Add to wishlist Add to compareAsk about productDescription
Product Information
-
Product Name: Rilastil Hydrotenseur Matt Restructuring Gel Cream
-
Category: Anti-Aging Moisturizer / Sebum-Regulating Care
-
Problem it solves: This formula addresses the dual challenge of treating visible signs of aging—such as loss of firmness and fine lines—while managing the oily T-zone and enlarged pores characteristic of combination skin.
-
Key benefits:
-
Supports the skin’s natural elasticity to help smooth and “fill” the appearance of wrinkles.
-
Contributes to a refined skin texture by minimizing the visibility of pores.
-
Helps to regulate sebum production, providing a long-lasting matte finish.
-
Supports the skin barrier, ensuring deep hydration without a heavy or greasy residue.
-
-
Ingredients or features:
-
Hyaluronic Acid (Three Molecular Weights): Ensures optimal hydration across different layers of the epidermis.
-
Lupeol and Miolift: Help to restructure the dermal matrix and promote a visible lifting effect.
-
Ceramides: Help to repair and strengthen the skin’s protective barrier.
-
Mattifying Actives: Specifically selected to absorb surface oils and provide a soft-focus effect.
-
-
How to use: Apply to the face and neck after your cleansing routine in the morning and evening. Massage with light, upward strokes until the gel-cream is completely absorbed.
-
Target audience: Individuals with combination or oily skin who are seeking an effective anti-aging solution that does not cause greasiness or congestion.
-
Requirements: For external use only. Store away from heat sources.







Reviews
There are no reviews yet.